NASDAQ: DTIL
Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stanley FrankelDirector2026-09-281,000$6.00
$6.00kBuy
Melinda BrownDirector2026-09-251,135$6.27
$7.12kBuy
Geno J. GermanoDirector2026-09-252,609$6.28
$16.38kBuy
J. Jefferson SmithChief Research Officer2026-02-184,925$3.84
$18.91kSell
Michael AmorosoPresident and CEO2026-02-1820,559$3.84
$78.95kSell
John Alexander KellyChief Financial Officer2026-02-188,149$3.84
$31.29kSell
Dario ScimecaGeneral Counsel and Secretary2026-02-184,925$3.84
$18.91kSell
Michael AmorosoPresident and CEO2026-01-2234,799$4.17
$145.11kSell
John Alexander KellyChief Financial Officer2026-01-2115,213$4.03
$61.31kSell
J. Jefferson SmithChief Research Officer2026-01-2110,200$4.03
$41.11kSell

1 of 2

DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pharma Ag Novartis44.41%12,407,440$131.52MInsider
Venbio Global Strategic Fund LP15.27%4,265,141$45.21MInsider
Derek Jantz14.52%4,055,174$42.98MInsider
Fmr LLC13.38%3,738,248$39.63MInsider
Matthew R. Kane7.25%2,024,438$21.46MInsider
Michael Amoroso0.87%243,392$2.58MInsider
Tony Dung Ling Yao0.60%166,903$1.77MInsider
Abid Ansari0.52%144,401$1.53MInsider
J. Jefferson Smith0.46%129,857$1.38MInsider
John Alexander Kelly0.45%125,883$1.33MInsider

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL0.06%99.75%Net SellingNet Buying
SCTX0.00%61.25%Net Buying
ARCT0.09%12.98%
QSI0.02%48.06%Net BuyingNet Selling
KYTX0.06%42.88%Net Buying

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 0.06% institutional shareholders, 99.75% Precision Biosciences insiders, and 0.19% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 44.41% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $131.52M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.